Hypera SA (HYPMY)
4.195
-0.21
(-4.77%)
USD |
OTCM |
Dec 26, 16:00
Hypera EPS Diluted (Quarterly): 0.132 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Raia Drogasil SA | 0.0468 |
| CEL-SCI Corp. | -1.365 |
| AIM ImmunoTech, Inc. | -1.569 |
| IGC Pharma, Inc. | -0.0201 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 83.30M |
| Revenue (Quarterly) | 408.77M |
| Total Expenses (Quarterly) | 325.18M |
| Enterprise Value | 4.057B |
| Gross Profit Margin (Quarterly) | 58.93% |
| Profit Margin (Quarterly) | 20.38% |
| Earnings Yield | 5.56% |
| Operating Earnings Yield | 7.75% |
| Normalized Earnings Yield | 5.335 |